Home > Healthcare > Medical Devices > Diagnostic Devices > Point-of-Care Glucose Testing Market
Point-of-Care Glucose Testing Market Size
- Report ID: GMI11241
- Published Date: Sep 2024
- Report Format: PDF
Point-of-Care Glucose Testing Market Size
Point-of-Care Glucose Testing Market size was valued at around USD 3.4 billion in 2023 and is estimated to grow at 4.7% CAGR from 2024 to 2032. Point-of-care glucose testing refers to the process of measuring blood glucose levels at or near the site of patient care, rather than in a centralized laboratory. This testing is performed using portable and user-friendly devices that provide immediate results, allowing for quick decision-making in the management of diabetes and other conditions requiring glucose monitoring.
The rising incidence of diabetes is a significant driver of market growth. For instance, according to the World Health Organization (WHO), about 422 million people worldwide have diabetes in 2024, with the majority living in low- and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. This underscores the urgent need for reliable point-of-care glucose testing solutions to manage the growing diabetes burden effectively.
Additionally, technological advancements in glucose monitoring, the rising geriatric population, and the growing adoption of continuous glucose monitors are key factors driving market growth
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Point-of-Care Glucose Testing Market Size in 2023: | USD 3.4 Billion |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 4.7% |
| 2032 Value Projection: | USD 5.1 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 85 |
| Tables, Charts & Figures: | 161 |
| Segments covered: | Product Type, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Point-of-Care Glucose Testing Market Scope
